Drugs Made In America Acquisition Corp. Ordinary Shares
DMAANASDAQFinancial Services● Active
$10.61
+$0.00(+0.00%)
Market Cap$357738887
P/E Ratio—
52W High$10.61
52W Low$10.15
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DMAA · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.01B | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B |
| Net Income | $0.01B | ($0.00B) |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.19 | $-0.06 |
| Wtd Avg Shares | 0.02B | 0.01B |
| EBITDA | ($0.00B) | $0.00B |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Drugs Made In America Acquisition Corp. Ordinary Shares data
About Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Income Statement
Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, DMAA reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.01B — a net profit margin of —.
Frequently asked questions
DMAA · 4 questionsDrugs Made In America Acquisition Corp. Ordinary Shares (DMAA) reported revenue of $0.00B for 2025, down —% year-over-year.
DMAA revenueDMAA salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08